Oregovomab
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for Oregovomab, covering 2017-07-14 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer [Phase 1, Phase 2]